10-K/A: Finnovate Acquisition Corp. Files Amended Annual Report Amid Delisting and Going Concern Doubts, Business Combination with Scage Faces Continued Delays and Reduced Valuation

Sentiment:

Annual Report Amendment


Finnovate Acquisition Corp. (FNVT) has filed an amended annual report for fiscal year 2024, revealing a net loss, significant shareholder redemptions, a Nasdaq delisting, and ongoing substantial doubt about its ability to continue as a going concern, despite shareholder approval for its proposed business combination with Scage International Limited.

Delay expectedThe initial business combination deadline was May 8, 2023, and has been extended multiple times to May 8, 2024 (2023 Extension), November 8, 2024 (Second Extension Amendment), May 8, 2025 (Third Extension Amendment), and most recently to November 8, 2025 (Fourth Extension Amendment).The 'Outside Date' for the Scage Business Combination Agreement has been extended from February 29, 2024, to October 31, 2024, then to March 31, 2025, and most recently to July 31, 2025.The deadline for the 'Reorganization' of Scage was extended from September 30, 2023, to July 20, 2024.
Capital raiseThe Sponsor issued a promissory note of up to $1,200,000 on June 2, 2023, to be deposited into the Trust Account to support the 2023 Extension.Sunorange issued a promissory note of up to $1,500,000 on November 8, 2023, for working capital expenses.Scage issued an unsecured promissory note of up to $1,500,000 on January 26, 2024, for the company's working capital needs.The Sponsor issued a promissory note of up to $225,000 on May 15, 2024, to be deposited into the Trust Account for the Second Extension Amendment.The Sponsor issued a promissory note of up to $259,588 on November 11, 2024, to be deposited into the Trust Account for the Third Extension Amendment.
Worse than expectedThe company reported a net loss of $215,486 for the fiscal year ended December 31, 2024, a negative shift from the prior year's net income.The Trust Account balance has been significantly depleted due to high shareholder redemptions across multiple extension votes, indicating a substantial loss of capital for the potential business combination.The company was delisted from Nasdaq on November 12, 2024, and now trades on the less liquid OTC Markets, which is a major negative outcome for a SPAC.The auditors have expressed substantial doubt about the company's ability to continue as a going concern, signaling severe financial instability and uncertainty about its future operations.The proposed business combination with Scage has seen its aggregate merger consideration reduced from $1.0 billion to $800 million, reflecting a lower valuation for the target.

Summary

  • Finnovate Acquisition Corp. (FNVT), a Special Purpose Acquisition Company (SPAC), filed an amended Annual Report on Form 10-K/A for the fiscal year ended December 31, 2024, primarily to include the authorized audit report and updated certifications.
  • The company reported a net loss of $215,486 for the year ended December 31, 2024, a significant decline from a net income of $2,494,909 in the prior year, largely due to decreased interest income from its Trust Account and ongoing general and administrative expenses.
  • FNVT's cash outside the Trust Account was critically low at $769 as of December 31, 2024, with a working capital deficit of $5,086,771.
  • The company has faced substantial shareholder redemptions across multiple extension votes: $132.6 million in May 2023, $26.9 million in May 2024, $16.16 million in November 2024, and $9.0 million in May 2025, severely depleting the Trust Account.
  • The Trust Account balance decreased from $51,200,344 as of December 31, 2023, to $10,208,877 as of December 31, 2024.
  • FNVT was delisted from Nasdaq on November 12, 2024, due to non-compliance with listing rules, including failure to meet the business combination deadline and minimum shareholder requirements, and its securities now trade on the OTC Markets.
  • The proposed business combination with Scage International Limited, a zero-emission solution provider, has been repeatedly delayed and amended, with the aggregate merger consideration reduced from $1.0 billion to $800 million.
  • The deadline for completing the business combination has been extended multiple times, currently set for November 8, 2025, with further extensions possible but uncertain.
  • The company's management has identified a material weakness in its internal control over financial reporting, specifically regarding complex financial instruments, professional fees, prepaid expenses, and related party payables/notes.
  • The audit report includes an explanatory paragraph highlighting substantial doubt about the company's ability to continue as a going concern due to its limited operating capital and the uncertainty of completing the business combination.

Sentiment

Score: 2

Explanation: The sentiment is overwhelmingly negative due to the company's delisting from Nasdaq, significant shareholder redemptions, a net loss, a severe working capital deficit, and the auditor's going concern warning. While the business combination proposal was approved, the repeated delays, amendments, and reduced valuation of the target indicate substantial challenges and uncertainty.

Positives

  • Shareholders approved the Scage Business Combination proposal on March 28, 2025, indicating a path forward for the merger, subject to closing conditions.
  • The company has secured multiple promissory notes from its Sponsor and Scage to fund extensions and working capital, demonstrating continued financial support from key parties.
  • The Sponsor has deposited an aggregate of $1,468,264 into the Trust Account to support the various extensions of the business combination period.

Negatives

  • The company reported a net loss of $215,486 for the year ended December 31, 2024, a significant deterioration from the prior year's net income.
  • The Trust Account balance has been severely depleted due to substantial shareholder redemptions, decreasing from $175,950,000 at IPO to $10,208,877 as of December 31, 2024.
  • Finnovate Acquisition Corp. was delisted from Nasdaq on November 12, 2024, and its securities now trade on the less liquid OTC Markets, impacting investor liquidity and visibility.
  • The company faces substantial doubt about its ability to continue as a going concern, as highlighted by its auditors, due to its limited cash resources and the uncertainty of completing the business combination by the November 8, 2025 deadline.
  • The aggregate merger consideration for the Scage Business Combination was reduced from $1.0 billion to $800 million, indicating a lower valuation for the target company.
  • The business combination agreement with Scage has been amended multiple times, extending deadlines and reflecting ongoing challenges in closing the transaction.
  • The company has identified material weaknesses in its internal control over financial reporting, raising concerns about financial accuracy and compliance.

Risks

  • Inability to complete the initial Business Combination, including the Scage Business Combination, within the Combination Period (currently November 8, 2025).
  • Expectations around the performance of the prospective target business (Scage) may not be realized.
  • Difficulty in retaining or recruiting required officers, key employees, or directors following the initial Business Combination.
  • Conflicts of interest among officers and directors due to their time allocation to other businesses.
  • Inability to obtain additional financing to complete the initial Business Combination or reduce the number of Public Shareholders requesting redemption.
  • Issuance of Ordinary Shares to investors in connection with the initial Business Combination at a price less than the prevailing market price, leading to dilution.
  • Trust Account funds may not be fully protected against third-party claims or bankruptcy, potentially reducing the per-share redemption amount.
  • Lack of an active market for public securities and limited liquidity due to Nasdaq delisting.
  • Financial performance following a Business Combination may be negatively affected by the target's lack of an established record of revenue, cash flows, and experienced management.
  • Increased competition to find an attractive target for an initial Business Combination, potentially increasing costs and hindering suitability.
  • Changes in the market for directors and officers liability insurance could make it more difficult and expensive to complete a Business Combination.
  • Potential for the Excise Tax to be imposed on redemptions of Ordinary Shares if the Business Combination involves a U.S. company.
  • Uncertainty regarding the listing of Pubco's securities on Nasdaq post-combination, which could prevent the merger or result in trading on over-the-counter markets.
  • Cyber incidents or attacks could result in information theft, data corruption, operational disruption, and/or financial loss.
  • Changes in laws or regulations, or failure to comply, may adversely affect the business and ability to complete the Business Combination.
  • Risk of being deemed an investment company under the Investment Company Act, leading to burdensome compliance requirements and restricted activities.
  • Reduced interest income on Trust Account funds due to holding them in an interest-bearing demand deposit account instead of U.S. government securities.
  • Substantial doubt about the company's ability to continue as a going concern.
  • Material weakness in internal control over financial reporting, potentially affecting accurate and timely financial reporting.
  • The share price of the post-Business Combination company may be less than the Redemption Price of Public Shares.
  • Changes in international trade policies, tariffs, and treaties could adversely affect the search for a target or the performance of a post-Business Combination company.

Future Outlook

The company's future outlook is highly uncertain, with a primary focus on completing the Scage Business Combination by November 8, 2025. Management intends to pursue this combination but acknowledges substantial doubt about its ability to continue as a going concern if the transaction is not consummated. The company may seek further extensions to the Combination Period, which would require shareholder approval and could lead to additional redemptions. The ability to list Pubco's securities on Nasdaq post-combination is also a critical factor for the future success of the combined entity.

Management Comments

  • "Our Management Team is led by Calvin Kung, our Chief Executive Officer, and Wang Chiu (Tommy) Wong, our Chief Financial Officer."
  • "We must complete our initial Business Combination by November 8, 2025 (unless being extended by shareholders approval). If our initial Business Combination is not consummated by such date, then our existence will terminate, and we will distribute all amounts in the Trust Account."
  • "Management has determined that the automatic liquidation, should a Business Combination not occur, and potential subsequent dissolution also raise substantial doubt about our ability to continue as a going concern for a period of time within one year after the date that the unaudited condensed financial statements are issued."
  • "While management intends to complete a Business Combination on or before November 8, 2025, it is uncertain whether we will be able to do so."
  • "Our Management performed additional analysis as deemed necessary to ensure that our audited financial statements included in this Report were prepared in accordance with GAAP. Accordingly, Management believes that the audited financial statements included in this Report present fairly, in all material respects, our financial position, results of operations and cash flows of the periods presented."
  • "We have enhanced, and will continue to enhance, internal controls and procedures, including access to accounting literature, identification and consideration of third-party professionals with whom to consult regarding complex accounting applications and implementing additional layers of reviews in the financial close process."

Industry Context

As a SPAC, Finnovate Acquisition Corp. operates within a highly competitive and evolving financial landscape. The 2024 SEC SPAC Rules have introduced additional disclosure requirements and regulatory scrutiny, potentially increasing costs and time for business combinations. The company's delisting from Nasdaq and reliance on OTC Markets for trading places it at a significant disadvantage compared to other SPACs or operating companies seeking public market access. The target, Scage International Limited, is in the zero-emission solution provider sector in China, focusing on heavy-duty NEV trucks and e-fuel solutions, an industry with significant growth potential but also regulatory and market risks specific to China.

Comparison to Industry Standards

  • Finnovate's significant shareholder redemptions (over 90% of initial shares redeemed) are substantially higher than typical SPAC redemption rates, indicating a strong lack of investor confidence in the company's ability to execute its business combination or the attractiveness of the target.
  • The delisting from Nasdaq is a severe deviation from industry standards for SPACs, which are formed with the explicit goal of listing a target company on a major exchange. This significantly reduces liquidity and investor appeal compared to peers.
  • The repeated extensions of the business combination deadline and the reduction in the target's valuation (from $1 billion to $800 million) suggest difficulties in deal execution and potentially a less favorable outcome for initial investors compared to successful SPAC mergers.
  • The identification of material weaknesses in internal controls is a red flag, indicating a lack of robust financial reporting infrastructure, which is below the expected standard for a publicly traded entity, even a SPAC.
  • The company's current cash position outside the Trust Account ($769) and substantial working capital deficit ($5.08 million) are far below industry norms for operating companies and even for SPACs managing pre-combination expenses, highlighting severe liquidity constraints.

Management Changes

RolePrevious PersonNew PersonEffective DateReason
Chairman of the Board and Chief Executive OfficerDavid GershonCalvin KungMay 8, 2023Part of the Sunorange Investment agreement.
Chief Financial Officer and DirectorRon GolanWang Chiu (Tommy) WongMay 8, 2023Part of the Sunorange Investment agreement.
Chief Investment OfficerJonathan OphirNAMay 8, 2023Resignation upon closing of the Sunorange Investment.
Senior ConsultantUri ChaitchikNAMay 8, 2023Resignation upon closing of the Sunorange Investment.
DirectorMitch GarberNAUpon expiration of Waiting PeriodResignation upon closing of the Sunorange Investment; vacancies filled by New Management.
DirectorGustavo SchwedNAUpon expiration of Waiting PeriodResignation upon closing of the Sunorange Investment; vacancies filled by New Management.
DirectorNadav ZoharNAUpon expiration of Waiting PeriodResignation upon closing of the Sunorange Investment; vacancies filled by New Management.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Audit Committee CompositionThe Audit Committee consists of Chunyi (Charlie) Hao, Tiemei (Sarah) Li (Chair), and Sanjay Prasad. Ms. Li is designated as an audit committee financial expert.May 2023Ensures compliance with Nasdaq listing standards and SEC rules for audit committee independence and expertise.
Compensation Committee CompositionThe Compensation Committee consists of Chunyi (Charlie) Hao (Chair), Tiemei (Sarah) Li, and Sanjay Prasad.May 2023Ensures compliance with Nasdaq listing standards and SEC rules for compensation committee independence.
Code of Ethics AdoptionA Code of Ethics applicable to directors, officers, and employees has been adopted.NAEstablishes ethical guidelines and promotes integrity within the company.
Insider Trading Policies and Procedures AdoptionInsider trading policies and procedures governing securities transactions by directors, officers, and employees were adopted.April 21, 2025Aims to prevent insider trading violations and promote compliance with securities laws, including Rule 10b5-1.
Executive Compensation Clawback Policy AdoptionAn Executive Compensation Clawback Policy was adopted to comply with SEC and Nasdaq rules, allowing for mandatory recovery of erroneously awarded incentive-based compensation from executive officers in case of financial restatement.November 30, 2023 (effective October 2, 2023)Enhances accountability for executive compensation and aligns with regulatory requirements for financial integrity.

Legal Proceedings

  • To the knowledge of Management, there is no material litigation currently pending or contemplated against the company, any of its officers or directors in their capacity as such, or against any of its property.

Related Party Transactions

  • The Sponsor purchased 4,312,500 Founder Shares for $25,000 in March 2021, representing approximately 20% of outstanding shares after the IPO.
  • The Sponsor and EarlyBirdCapital purchased an aggregate of 8,800,000 Private Placement Warrants for $1.00 per warrant, totaling $8,800,000.
  • An Administrative Services Agreement was in place, where the company paid its Sponsor $3,000 per month for office space, utilities, and administrative support services, which was terminated as of October 1, 2024.
  • The Sponsor, officers, and directors are reimbursed for bona-fide, documented out-of-pocket expenses incurred on the company's behalf.
  • A $250,000 promissory note from the Sponsor in March 2021 was fully repaid on November 8, 2021.
  • The Working Capital Loan from the Sponsor was canceled in full on May 8, 2023, and reclassified as an in-substance capital contribution.
  • The June 2023 Promissory Note of up to $1,200,000 was issued to the Sponsor to support the 2023 Extension, with $1,100,000 outstanding as of December 31, 2024.
  • The November 2023 Promissory Note of up to $1,500,000 was issued to Sunorange (general partner of the Sponsor) for working capital expenses, with $1,204,630 outstanding as of December 31, 2024.
  • The May 2024 Promissory Note of up to $225,000 was issued to the Sponsor to support the May 2024 Extension, with $225,000 outstanding as of December 31, 2024.
  • The November 2024 Promissory Note of up to $259,588 was issued to the Sponsor to support the November 2024 Extension, with $43,264 outstanding as of December 31, 2024.
  • On January 3, 2025, the Sponsor distributed its Class A and B ordinary shares and private placement warrants to its constituent members, including Calvin Kung (CEO) and Wang Chiu (Tommy) Wong (CFO/Director).

Stakeholder Impact

  • **Shareholders**: Public shareholders have experienced significant dilution and value erosion due to massive redemptions and the company's delisting from Nasdaq, limiting liquidity and trading options. The going concern warning poses a substantial risk to their remaining investment.
  • **Employees/Management**: The management team faces immense pressure to complete the business combination by the extended deadline to avoid liquidation. Changes in management roles have occurred, and future roles are uncertain post-combination.
  • **Creditors**: The company's low cash balance outside the Trust Account and the going concern warning raise concerns about its ability to meet short-term obligations, although the Sponsor has agreed to indemnify the Trust Account against certain third-party claims.
  • **Scage International Limited**: The target company, Scage, is impacted by the delays and amendments to the business combination agreement, including a reduced valuation. Its ability to access public markets and anticipated financing is contingent on the successful closing of the merger.
  • **Sponsor/Related Parties**: The Sponsor and Sunorange have provided significant financial support through promissory notes and contributions to the Trust Account, indicating their continued commitment, but also exposing them to the risks of the business combination's failure.

Next Steps

  • Complete the Scage Business Combination by the extended deadline of November 8, 2025.
  • Fulfill remaining closing conditions for the Scage Business Combination, including obtaining regulatory approvals, third-party consents, and meeting the $15,000,000 PIPE investment requirement.
  • Resolve the dispute with Shenzhen Deju Brothers Special II Corporate Management Partnership (Limited Partnership) regarding Scage's equity and ensure the release of the judicial freeze on Nanjing Scage's equity interest.
  • Pubco will seek to be listed on Nasdaq upon consummation of the business combination, requiring compliance with initial listing criteria.
  • Continue efforts to enhance internal controls and procedures to address identified material weaknesses in financial reporting.

Key Dates

DateDescription
2021-03-15Finnovate Acquisition Corp. incorporated in the Cayman Islands.
2021-11-08Initial Public Offering (IPO) consummated, selling 15,000,000 Units at $10.00 per Unit.
2021-11-12Company closed on the underwriters' full exercise of the over-allotment option, selling an additional 2,250,000 Units.
2023-05-08Extraordinary General Meeting (2023 EGM) held; shareholders approved proposals including extending the business combination deadline to May 8, 2024, and the closing of the Sunorange Investment.
2023-05-18Redemptions from the 2023 EGM were effected, totaling approximately $132.6 million.
2023-06-02Company issued a promissory note of up to $1,200,000 to the Sponsor to support the 2023 Extension.
2023-08-21Company entered into a Business Combination Agreement with Scage Future, Hero 1, Hero 2, and Scage International Limited.
2023-11-01Company instructed the trustee to liquidate investments in the Trust Account and hold funds in an interest-bearing demand deposit account.
2023-11-08Company issued a promissory note of up to $1,500,000 to Sunorange for working capital expenses.
2023-12-31Fiscal year end for 2023 financial statements.
2024-01-22Received deficiency notice from Nasdaq regarding non-compliance with the annual meeting requirement.
2024-01-26Company issued an unsecured promissory note of up to $1,500,000 to Scage for working capital needs.
2024-03-07Submitted a plan to Nasdaq to regain compliance with the Annual Meeting Requirement.
2024-05-02Extraordinary General Meeting (May 2024 EGM) held; shareholders approved extending the business combination deadline to November 8, 2024.
2024-05-06Received deficiency notice from Nasdaq regarding non-compliance with the minimum 400 total shareholders requirement.
2024-05-15Company issued an unsecured promissory note of up to $225,000 to the Sponsor to support the Second Extension Amendment.
2024-06-18First Amendment to Business Combination Agreement entered, reducing consideration to $800M and extending Reorganization deadline to July 20, 2024, and Outside Date to October 31, 2024.
2024-07-03Nasdaq Hearings Panel granted request for continued listing, subject to completing business combination by November 4, 2024.
2024-10-01Administrative Services Agreement with Sponsor terminated.
2024-10-13Amended and restated the agreement with a third-party consultant, reducing the contingent fee.
2024-10-31Second Amendment to Business Combination Agreement entered, extending the Outside Date to March 31, 2025.
2024-11-05Announced waiver of right to withdraw $50,000 of interest accrued on Trust Account for dissolution expenses.
2024-11-06Extraordinary General Meeting (November 2024 EGM) held; shareholders approved extending the business combination deadline to May 8, 2025.
2024-11-08Received written notice from Nasdaq Panel indicating delisting of securities from Nasdaq.
2024-11-11Company issued an unsecured promissory note of up to $259,588 to the Sponsor to support the Third Extension Amendment.
2024-11-12Trading in company securities suspended on Nasdaq; began quoting on OTC Markets.
2024-12-31Fiscal year end for 2024 financial statements.
2025-01-03Sponsor consummated a distribution of its assets, including Class A and B ordinary shares and private placement warrants, to its constituent members.
2025-03-24Audit Committee dismissed Marcum LLP and engaged HTL International, LLC as the new independent registered public accounting firm.
2025-03-28Extraordinary General Meeting (Scage Business Combination Meeting) held; business combination proposal approved by Finnovate shareholders.
2025-04-02Third Amendment to Business Combination Agreement entered, extending the Outside Date to July 31, 2025.
2025-04-21Adopted Insider Trading Policies and Procedures.
2025-04-28Nasdaq notified the Company of impending delisting announcement on April 30, 2025.
2025-05-06Extraordinary General Meeting (May 2025 EGM) held; shareholders approved extending the business combination deadline to November 8, 2025.
2025-05-21Nasdaq filed a Form 25 with the SEC to complete the delisting.
2025-06-05Date of filing of the 10-K/A and date for outstanding share count.
2025-07-31Current Outside Date for the Scage Business Combination Agreement.
2025-11-08Current deadline for the Company to complete a Business Combination.

Recommendation

sell

Keywords

SPAC, Finnovate Acquisition Corp, Scage International Limited, Business Combination, De-SPAC, SEC Filing, 10-K/A, Financial Report, Shareholder Redemptions, Nasdaq Delisting, Going Concern, Promissory Notes, Trust Account, Corporate Governance, Risk Factors, Merger Agreement, Zero-emission vehicles, China, Electric trucks

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.